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Abstract
Background: Polycystic ovary syndrome (PCOS) is an oxidative state resulting in
ovarian dysfunction. Licorice is one of the natural antioxidants used for the treatment
of infertility.
Objective: To evaluate the effect of licorice extract on ovarian morphology, oocyte
maturation, and embryo development in PCOS-induced mice.
Materials and Methods: thirty-two female NMIR mice were divided into four groups
(n = 8/each): control group receiving no treatment (group I); PCOS group injected with
estradiol valerate once daily for 21 days (group II); and experimental groups receiving
either 100 mg/kg (group III) or 150 mg/kg (group IV) licorice by gavage along with
estradiol valerate once daily for 3 wk. Serum levels of the testosterone and estrogen
weremeasured using ELISA kit. Histological study of ovarieswas evaluated, and oocyte
maturation, fertilization rate, and embryo development were determined after in vitro
maturation.
Results: Experimental groups (III, IV) had significantly higher testosterone and estradiol
levels compared to the PCOS group (p ≤ 0.001). A significant increase in the number
of healthy follicles (primary, preantral follicles) (p = 0.001), corpus luteum (p = 0.001)
with significant decrease in the number of atretic follicles (primary, preantral, cystic
follicles) (p ≤ 0.001) was seen in the experimental groups. Increase in the fertilization
rate (p ≤ 0.001) and blastocyst stage embryos (p = 0.02, p = 0.004) were observed in
the experimental groups.
Conclusion: It appears that the two doses (100 mg and 150 mg) of licorice could
decrease ovarian cyst and improve the fertilization rate of oocyte and embryo
development in PCOS mice. However, there was no statistically significant difference
between the two experimental groups.
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1. Introduction
Polycystic ovary syndrome (PCOS) is
a hormonal imbalance and metabolic
disorder affecting about 8-13% of all
women during their reproductive age.
Anovulation, hyperandrogenism, polycystic
ovary, hyperinsulinism, hirsutism, and elevated
concentrations of LH are some of the
major implications of PCOS (1, 2). It is seen
that the increased enzymatic activities of
17αhydroxylase/17, 20 lyase, 3β-hydroxysteroid
dehydrogenase, as well as the side chain
cleavage enzyme lead to hyperandrogenism
in patients with PCOS (3, 4). In addition, the
biosynthesis of estrogens from androgens is
catalyzed by aromatase; hence, a deficiency
in aromatase activity may lead to intraovarian
disturbances and hormonal imbalance (5).
An ovulatory cycle may lead to infertility
resulting in a need for assisted reproductive
techniques (6). Moreover, in vitro maturation (IVM)
is a relatively newmethod in assisted reproductive
techniques, in which immature oocytes are
extracted from the ovaries without gonadotropin
stimulation, thus limiting the risk of ovarian
hyperstimulation syndrome compared to in vitro
fertilization (IVF) technique (7). Currently, using
various herbal remedies as natural antioxidants
is suggested for improving all clinical features of
PCOS to recover the menstrual cycle and normal
serum hormones levels. Therefore, antioxidant
supplementation are known to be effective in
reducing testosterone, polycystic ovaries, and
improving reproductive cycles (8, 9).
licorice (Glycyrrhiza glabra) has been used
to treat different diseases for many years (10).
Multiple biological activities such as the powerful
antioxidative, antifatigue, antibacterial, antiviral,
antiproliferative, and estrogenic activity of licorice
have been demonstrated in several experimental
evidence (11, 12). Therefore, some studies have
suggested licorice extract as a possible candidate
for the treatment of infertility as well as PCOS (13).
Previous studies have revealed that blocking the
activity of 3β-hydroxysteroid dehydrogenase
(3HSD), 17-hydroxysteroid dehydrogenase
(17HSD), and 17-20 lyase, and stimulating the
activity of aromatase, while also affecting the
5a- and 5b-reductase activity, are some effects
of licorice extract (14, 15). All these enzymes
are involved in the synthesis and/or metabolism
of androgens and estrogens (14). Lakshmi and
colleagues demonstrated that inhibiting 17HSD,
licorice could decrease serum testosterone in
PCOS women, indicating that licorice has an
anti-testosterone activity that may be beneficial
in treating women with PCOS (16). Additionally,
licorice exhibits estrogenic properties that could
result in aromatase stimulation activity (17), and
currently supplements of licorice are used for
overweight PCOS patients (18). It was recently
demonstrated that licorice extract can result in an
improvement in IVF results in mice (19). Also, data
show an improvement of PCOS symptoms such
as imbalance in the hormonal levels and irregular
ovarian follicles in letrozole-induced female rats
(20).
To the best of our knowledge, possible
beneficial and adverse effects of licorice extract
along with IVM on female fertility have not
been studied yet. As a result, the current study
intended to examine the various concentrations
of licorice extract on the histological changes
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of the ovaries along with oocyte maturation and
embryo development in mice induced with PCOS.
2. Materials and Methods
2.1. Chemicals
Material and reagents used in the present study
were purchased from Sigma-Aldrich (Germany),
unless otherwise mentioned.
2.2. Animals and experimental design
Adult Female (6-7 wk old) and male (8-12 wk
old) Naval Medical Research Institute (NMRI) mice
were obtained from the breeding center at the
Faculty of Science, Urmia University (Urmia, Iran).
The mice were housed in a 12-hr light/dark cycle,
at 25 ± 1°C and 50-60% humidity, and had free
access to standard pellet diet andwater ad libitum.
The female mice were randomly assigned into
four groups (n = 8/group) as follows:
• Group I: mice receiving no treatment (control
group)
• Group II: PCOS was induced in mice through
0.2 mg estradiol valerate intramuscularly once
daily for 3 wk.
• Group III: mice received 100 mg/kg licorice
extract daily by gavage along with a single-dose
injection of 0.2 mg estradiol valerate once a day
intramuscularly for 3 wk.
• Group IV: mice received 150 mg/kg licorice
extract daily by gavage along with a single-dose
injection of 0.2 mg estradiol valerate once a day
intramuscularly for 3 wk (Figure 1).
Additionally, in the present study, 0.2 mg/kg
body weight (BW) single dose of EV (Aburaihan,
Iran) was injected subcutaneously for 21 days (21).
Studies have shown that the administration of
estradiol valerate leads to anovulation and cystic
ovarian morphology (22).
2.3. Preparation of licorice extract
The licorice was collected from a local farm in
Urmia, north-west of Iran. The collected samples
were identified by the Plant Botanical Laboratory,
Faculty of Agriculture Science, Urmia University
of Iran. The plant was washed with water and
dried in the shade. Then, they were pulverized
into a powder using a mixer grinder. To prepare
the hydro-alcoholic extract, the powder of the
dried licorice was extracted for 72 hr in ethanol
80%, following a solvent evaporation using a
rotary evaporator. Next, it was completely dried
and collected. Finally, the extract of the licorice
was dissolved in normal saline to achieve an
appropriate concentration.
2.4. Blood sampling
After the injection, the female mice were
sacrificed under anesthesia, before drawing
blood (2 mL) from the heart. Blood serum was
separated by centrifuging the blood samples at
6000 g for 5 min. Serum samples were stored
at -70°C for future analysis. Serum testosterone
and estrogen concentrations were assessed
through immune-radiometric techniques using
commercially available Elisa kits (diaplus, USA)
according to the manufacturer’s guidelines (23).
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2.5. Histological analysis
Ovarian tissue was removed for histological
examination following fixation in 10% formalin.
Afterward, the samples were cut serially at
5 μm and stained by hematoxylin and eosin.
In the final stage, the stained slides taken
from the ovaries were observed under a light
microscope. The observed follicle was defined
in six groups based on the morphology and
diameter: primordial follicles (PRIF), in which the
oocyte was closely surrounded by one layer
of flat granulosa cells; Primary follicles (PF),
where the growing oocyte was surrounded
by one layer of cuboidal granulosa cells;
preantral follicles (PAF), where several layers
of granulosa cells surround the oocyte with
no cavity within; Antral follicles (AF), where the
oocyte is surrounded by cumulus oophorus
cells within the cavity of antrum forming; Cystic
follicles (CF); and corpus luteum (CL). Thereafter,
all follicles were classified as healthy or atretic.
The characterization of follicular atresia was
done by the presence of pyknotic nuclei in the
granulosa cells, degeneration of the granulosa
cell layer from the basement membrane, and
change in the oocyte morphology. Follicles were
then counted in each section and classified
according to the work of Radavelli-Bagatini (24,
25).
2.6. Oocyte collection
The NMRI female mice were superovulated
by an intraperitoneal injection of 7.5 IU of
pregnant mare serum gonadotropin (PMSG,
Folligon, Netherlands). After 48 hr, they were
euthanized by cervical dislocation, and ovaries
were dissected and washed several times before
being transferred into a preheated dissecting
medium containing α-MEM supplemented
with 5% FCS, 100 μg/ml penicillin, and 50
μg/ml streptomycin. under a stereomicroscope
Germinal vesicle (GV)-stage oocytes of the
ovarian follicles were aseptically harvested
by aspiration from follicles with a 26-gauge
needle in a sterile petri dish, and released in the
culture medium and washed several times (26,
27).
2.7. In vitro maturation (IVM)
The IVM medium consisting of complete
MEM containing 100 IU/ml recombinant human
follicular-stimulating hormone (rhFSH), and 7.5
IU/ml human chorionic gonadotrophin (hCG).
The GV was transferred to 25 µl drops covered
with mineral oil and cultured for 16-18 hr at
37°C in 5% CO2 and humified atmosphere. The
maturation status of the oocytes, according to
polar body extrusion, was assessed under a
stereomicroscope (Model TL2, Olympus Co.,
Tokyo, Japan). Oocytes maturation was evaluated
by detecting the first polar body extrusion as
an indicator of the oocytes having reached
the metaphase II (MII) stage. Oocytes with the
extruded first polar body (PB1) were used for IVF
(28).
2.8. IVF
The oocytes in the MII stage were obtained
from the different groups and fertilized by sperm
Page 868 https://doi.org/10.18502/ijrm.v13i10.7771
International Journal of Reproductive BioMedicine Effects of licorice on PCOS
acquired from the cauda epididymides of 8-
10 wk-old male mice with proven fertility. The
epididymis was isolated from testes and placed
in a petri dish containing 1 ml of equilibrated HTF
medium supplemented with 4 mg/ml BSA. The
epididymides were then cut and gently pressed
allowing the spermatozoa to swim out into the
culture media, and then allowed to incubate at 5%
CO2 and 37°C for 30 min. Thereafter, spermatozoa
were added to the 20 µl IVF droplets containing
the oocytes and incubated again at 37°C, 5%
CO2 humidified atmosphere for 4-6 hr. Resulting
embryos were then cultured at 37°C in 5% CO2
humidified incubator for 5 hr (28).
2.9. Assessment of oocyte maturation
Finally, the number of oocytes at GV, MII
stages, and the number of two-pronuclear
(2PN) formations were recorded using a stereo
microscope. While the two-cell embryos were
evaluated 24 hr after fertilization, the percentage
of blastocyst-stage embryos was calculated on
days 4 and 5 of fertilization (28).
Animal (n = 32) 
Experimental design 
Group IV: mice received 150 
mg/kg licorice extract 0.2 mg 
estradiol valerate for 3 wk 
Group III: mice received 100 
mg/kg licorice extract 0.2 mg 
estradiol valerate for 3 wk 
Group II: PCOS was induced 
in the mice by 0.2 mg for 3 wk 
 
Group I: mice were not 
injected  
Mice were sacrificed under anesthesia 










Figure 1. Flow chart of the experimental design.
2.10. Ethical consideration
All animal experiments and study protocols
were approved by the educational assistant of
the Faculty of Science, University of Urmia, Urmia,
Iran.
2.11. Statistical analysis
Data presented as mean ± standard deviation
(SD). The differences between groups were
analyzed by ANOVA, followed by Tukey’s test
using the SPSS software (Statistical Package for




As shown in Table I, testosterone and estrogen
levels increased significantly in the PCOS group
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compared to the control group (p ≤ 0.001)
(Table I). The administration of licorice at 100
mg/kg/day and 150 mg/kg/day significantly
reduced the testosterone and estrogen levels
in the experimental groups compared to the
PCOS group after 3 wk (p ≤ 0.001). However,
the testosterone and estrogen levels (p = 0.18,
p = 0.27) were not significantly different between
the experimental groups (Table I).
3.2. Ovarian morphology
In the control group, ovarian tissues had normal
histological appearance (Figure 2a). The number
of healthy PRIF was not significantly different
between the groups. While in the PCOS group,
the number of healthy follicles were lower than the
control group (PF (p = 0.002), PAF (p = 0.02), AF
(p = 0.01)) (Table II). In the experimental groups,
the number of healthy follicles PF (p = 0.001,
p = 0.002), PAF (p = 0.01) were higher than the
PCOS group. Moreover, there were no significant
changes in the number of healthy follicles in
the experimental groups (Table II). Morphological
studies in the PCOS group showed that the
number of atretic follicles PRIF (p = 0.01), PF
(p = 0.002) in this group were significantly higher
compared to the control group (Table III). Also,
an evaluation of the number of atretic follicles
PF (p ≤ 0.001), PAF (p = 0.02, p = 0.03)
showed a significant decrease in the experimental
groups compared to the PCOS group (Table III).
The PCOS group showed a highly significant
increase in CF (p = 0.001) (Figure 2b). And
a reduction in the number of corpora luteal
(p = 0.02) as compared to the control group
(Figure 2c, d). Also, in experimental groups,
CF (p = 0.02, p = 0.01) were lower than the
PCOS group and an increase in the number
of CL (p = 0.001, p ≤ 0.001). However, there
were no significant changes in the number of
atretic follicles in the experimental groups (Table
IV).
3.3. IVM of oocytes
As shown in Table V, the percentage of
MII, fertilization rates, and blastocyst decreased
significantly in the PCOS group compared to
the control group (p ≤ 0.05). The daily oral
supplementation of 100 mg/kg/day and 150
mg/kg/day licorice extract for 3 wk resulted in an
increased fertilization rates in the experimental
groups in comparison with the PCOS group
(p ≤ 0.001). The percentage of MII (p = 0.28),
fertilization rates (p = 0.39), and blastocyst
(p = 0.91) were not statistically significant between
the experimental groups (Table V).
Table I. Effects of licorice extract on testosterone and estrogen levels in PCOS-induced mice
Groups Testosterone Estrogen
Group I 1.60 ± 0.28 8.85 ± 0.21
Group II 4.95 ± 0.21𝑎∗ 14.90 ± 0.14𝑎∗
Group III 2.10 ± 0.14𝑏∗∗ 10.75 ± 0.49𝑏∗∗
Group IV 1.60 ± 0.14𝑏∗∗ 10.05 ± 0.35𝑏∗∗
Data presented asMean± SD. one-way ANOVA test, *, ** Significant difference between the PCOS and other groups at p<0.05,
and p < 0.01, level respectively 𝑎Significant difference compared to the control group
Page 870 https://doi.org/10.18502/ijrm.v13i10.7771
International Journal of Reproductive BioMedicine Effects of licorice on PCOS
Table II. Effects of licorice extract on the healthy follicles number in PCOS-induced mice
Groups Primordial follicles Primary follicles Preantral follicles Antral follicles
Group I 44.66 ± 2.88 14.66 ± 0.57 7.66 ± 2.08 6.33 ± 1.52
Group II 47.33 ± 3.78 6.33 ± 1.52𝑎∗∗ 2.33 ± 1.15𝑎∗ 2.33 ± 0.57𝑎∗
Group III 52.66 ± 4.04 15.66 ± 2.88𝑏∗∗∗ 6.66 ± 0.57 3.33 ± 0.57
Group IV 47.33 ± 2.08 14.66 ± 1.52𝑏∗∗ 8.33 ± 2.51𝑏∗ 2.66 ± 1.52𝑏∗
Data presented as Mean ± SD. one-way ANOVA test, *, **, *** Significant difference between the PCOS and other groups at
p< 0.05, p< 0.01, and p< 0.001 level respectively. 𝑎Significant difference compared to the control group; 𝑏Significant difference
compared to the PCOS group
Table III. Effects of licorice extract on the atretic follicles number in PCOS-induced mice
Groups Primordial follicles Primary follicles Preantral follicles Antral follicles
Group I 14.66 ± 1.52 37.66 ± 1.52 9.66 ± 2.51 5.33 ± 0.57
Group II 22.00 ± 2.64𝑎∗ 49.66 ± 1.52𝑎∗∗ 14.33 ± 1.52 2.66 ± 1.15
Group III 23.33 ± 2.51𝑏∗∗ 32.66 ± 2.51𝑏∗∗∗ 8.00 ± 1.73𝑏∗ 4.33 ± 1.52
Group IV 21.33 ± 2.08𝑏∗ 32.33 ± 3.78𝑏∗∗∗ 8.33 ± 2.51𝑏∗ 2.66 ± 1.52
Data presented as Mean ± SD. one-way ANOVA test, *, **, *** Significant difference between the PCOS and other groups at
p< 0.05, p< 0.01, and p< 0.001 level respectively; 𝑎Significant difference compared to the control group; 𝑏Significant difference
compared to the PCOS group
Table IV. Effects of licorice extract on the cystic follicle and corpus luteum number in PCOS-induced mice
Groups Cystic follicles Corpus luteum
Group I 0 ± 0 7.33 ± 2.08
Group II 4.33 ± 0.57𝑎∗∗∗ 1.33 ± 0.57𝑎∗*
Group III 1.66 ± 0.57𝑏∗ 12.33 ± 2.08𝑏∗∗∗
Group IV 1.33 ± 1.52𝑏∗ 13 ± 2.64𝑏∗∗∗
Data presented as Mean ± SD. one-way ANOVA test, ∗, **, *** Significant difference between the PCOS and other groups at
p< 0.05, p< 0.01, and p< 0.001 level respectively. 𝑎Significant difference compared to the control group; 𝑏Significant difference
compared to the PCOS group
Table V. Effects of licorice extract on the germinal vesicles (GV), metaphase 2 (MII), fertilization rate, 2-cell stage, and blastocysts
in PCOS-induced mice
Groups GV follicles MII oocytes Fertilized oocytes 2-cell stage Blastocyst
Group I 50 82.00 ± 2.82 85.50 ± 2.12 78.50 ± 3.53 64.50 ± 3.53
Group II 40𝑎∗∗∗ 65.50 ± 3.53𝑎* 56.50 ± 2.12𝑎∗∗∗ 68.00 ± 1.41 41.00 ± 2.82𝑎∗∗
Group III 47 76.50 ± 3.53 78.00 ± 2.82𝑏∗∗∗ 71.50 ± 2.12 55.50 ± 2.12
Group IV 42𝑎∗ 78.50 ± 2.12 87.50 ± 0.70𝑏∗∗∗ 78.00 ± 4.24 62.00 ± 4.24
Data presented as Mean ± SD. one-way ANOVA test, ∗, **, *** Significant difference between the PCOS and other groups at
p< 0.05, p< 0.01, and p< 0.001 level respectively. 𝑎Significant difference compared to the control group; 𝑏Significant difference
compared to the PCOS group
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Figure 2. Histological changes in the ovarian tissue. Control (a): Section of ovary from a control group showing primordial follicles
(PRIF), primary follicles (PF), preantral follicles (PAF), and antral follicles (AF). PCOS (b): Section of ovary from a PCOSgroup showing
cystic follicle and atretic follicle. (c): Section of ovary from the experimental group (pro100) showing increased corpus luteum. (d):
Section of ovary from the experimental group (pro150) showing increased corpus luteum.
4. Discussion
In the present study, the PCOS phenotype was
induced with an aim to assess the effects of two
different dosage of licorice extract on histology,
maturation, and fertilization rates of the ovary in
PCOS-induced mice. Examining the testosterone
and estrogen levels, we could validate the effect
of licorice extract on the hormonal change. The
results obtained from the present study showed
increased levels of testosterone and estrogen in
the PCOS group, as well as a significant decrease
in the number of healthy follicles, CL, and increase
in atretic follicles. Moreover, the appearance of the
cyst in ovary were observed and matched with
the previous studies (29). Follicular development
and morphology formation in the ovaries were
a result of elevated levels of testosterone and
estrogen in the PCOS group (30). This refers to
hyperandrogenism that leads to the generation
of CF, reduction of healthy follicles, and increase
in the atretic follicles (31), thereby consequently
reducing the progesterone and estrogen levels
due to regression of the CL (32). Licorice is a
medicinal herb that is used extensively as it is
regarded as an important and safe medicine (32).
Nearly 500 components have been identified in
the licorice root, and glycyrrhizin and several other
flavonoids are the major components and most
abundant constituents of licorice (32).
Treating overweight women and alleviating
metabolic syndrome using licorice were examined
in clinical studies (33). In addition, licorice’s effect
on premenopausal syndrome and menopause
syndromes have also been investigated and
it showed promising and effective results in
alleviating these syndromes (34). Our findings
show that the exposure to licorice, both in doses
of 100 mg/kg/day and 150 mg/kg/day, significantly
decreased the testosterone and estrogen in
PCOS-induced mice. In addition, licorice could
increase the number of normal follicles andCL and
reduce the number of atretic follicles compared
to the PCOS group. There were no significant
differences in the testosterone, estrogen, number
of follicles among the experimental groups. Similar
to these results, a study demonstrated that licorice
extract improves the adverse effects resulting
from hyperandrogenism due to PCOS in female
mice and also has a positive effect on fertility (35).
Several studies showed that licorice extract
will lead to a reduction in intraovarian androgen
concentration when taken orally. Subsequently,
this results in decreasing the levels of androgen
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synthetized from estrogen, causing positive
feedback on the LH secretion (36). Catalyzing
the biosynthesis of estrogens from androgens
is done by aromatase, and deficiency in the
activity of this enzyme can be expected to
result in increased ovarian androgen production
and development of PCOS (37). Armanini and
colleague indicated when 17-hydroxysteroid
and 17-20-lyase are blocked and the activity
of aromatase increases, there is a significant
reduction in serum testosterone levels suggesting
that licorice could be considered as adjuvant
therapy of PCOS (36). A major finding of this
research was that licorice positively affected
IVM and IVF demonstrating a significantly higher
percentage of oocytes reachingMII and blastocyst
stages in both experimental groups as compared
to the PCOS group. This is in accordance with
the results obtained from Esmailii and colleagues,
who showed that licorice consumption improved
the oocyte maturation and number of follicles.
They also studied the beneficial effects of licorice
extract on oocyte maturation and infertility due to
its phytoestrogen properties (38).
Previous studies have shown oxidative stress
to be a prominent pathological feature of PCOS,
and women with PCOS have shown a decrease
in their total antioxidant status (37). Additionally,
antioxidants and reactive oxygen species (ROS)
play a physiological role in the reproductive
processes including oocyte maturation and
fertilization (39). Several previous investigations
have revealed that antioxidants can enhance the
maturation of oocytes and have a positive effect
on embryo development in mice (38). Ju and
colleagues have also demonstrated that licorice
flavonoids present a powerful antioxidant activity
and are capable of scavenging more free radicals
(40). Also, licorice is a source of phytoestrogen
containing herbal estrogen that is attributed to
the presence of isoflavones that are the key
components of the plant (41).
Some articles have reported that
phytoestrogens decrease the serum level
of androgens by increasing the level of sex
hormone-binding globulin (SHBG) (42). The
isoflavones glabridin and glabrene have estrogen-
like activity (12). Also, a study investigated the
role of estrogen in modulating sperm during
fertilization (43). Sexual development, such
as pubertal commencement, impaired estrous
cycling, ovarian function, and that functions of
the hypothalamus and pituitary can be regulated
by isoflavones, including formononetin (44).
Additionally, a study by Hajirahimkhan and
colleague indicated that liquiritigenin is an active
flavonoid isoliquiritigenin that may be cyclized of
liquiritigenin (34).
Tung and colleague identified that
formononetin and isoliquiritigenin are two
active components in licorice root that enhance
IVF (19). Although Tung and co-workers have
reported a not entirely clear relationship
between estrogen and fertilization, the two
phytoestrogens described here may promote
fertilization (45). It is possible that some of
the 500 components of licorice extract may
act synergistically to stimulate fertilization
(45). We observed that two different doses
of licorice as an antioxidant has numerous
beneficial effects on the hormonal changes
and improved ovarian morphology in mice with
PCOS. However, different doses of licorice did
not differ in the result. Our findings also showed
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that antioxidants and phytoestrogen activities
of licorice might be useful in the promotion of
IVM and fertilization. Therefore, we believe that
the licorice extract could be useful for managing
PCOS in women. Nevertheless, a limitation of
this study was the evaluation of oxidative stress
markers.
5. Conclusion
According to the results of the present study,
both doses of licorice may act as a useful
treatment for improving PCOS. Our findings
support that oral licorice extract intake can cause
a reduction in testosterone and estrogen levels,
and significantly enhance oocyte maturation,
fertilization, and embryo developmental rates in
mice. Also, licorice extract can improve ovary
morphology in PCOS-induced mice. However,
there was no statistically significant difference
between the two experimental groups. Since
no difference was found between the doses
of 100 mg and 150 mg, these conditions will
determine the final dose of atorvastatin for each
mouse.
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